Furosemide
-
Subject Areas on Research
- A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
- A major role for the EP4 receptor in regulation of renin.
- A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials.
- A reappraisal of loop diuretic choice in heart failure patients.
- Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight.
- Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT).
- Chloride transport inhibitors influence recovery from oxygen-glucose deprivation-induced cellular injury in adult hippocampus.
- Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
- Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
- Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
- Dangerous diuretics or death defying drugs?
- Death: The Simple Clinical Trial Endpoint.
- Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
- Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
- Diuretic exposure in premature infants from 1997 to 2011.
- Diuretic response in acute heart failure-an analysis from ASCEND-HF.
- Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
- Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
- Diuretic strategies in patients with acute decompensated heart failure.
- Door-to-Furosemide Therapy in the ED: New Quality Metric or Just a Piece of the Puzzle?
- Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
- Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
- Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.
- Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.
- Furosemide and mannitol suppression of epileptic activity in the human brain.
- Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
- Identification of a regulated Na/K/Cl cotransport system in a distal nephron cell line.
- Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.
- Managing the complications of plasma cell myeloma.
- Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
- Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
- Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
- Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
- Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.
- Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
- Reduction of folic acid-induced acute tubular injury by diuresis: an experimental model.
- Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.
- Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
- Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
- Reply: Efficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
- Role of microsomal prostaglandin E synthase 1 in the kidney.
- Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
- Sox6 as a new modulator of renin expression in the kidney.
- Suspension of medullary thick ascending limb tubules from the rabbit kidney.
- The chloride transporter Na(+)-K(+)-Cl- cotransporter isoform-1 contributes to intracellular chloride increases after in vitro ischemia.
- The effect of furosemide on intravascular volume status and electrolytes in patients receiving mannitol: an intraoperative safety analysis.
- The responses of atrial natriuretic factor concentrations to acute volume changes in conscious rats.
- The role of the c-Jun N-terminal kinases 1/2 and receptor-interacting protein kinase 3 in furosemide-induced liver injury.
- Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
- Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
- Two kinetically-distinct components of UDP-glucuronic acid transport in rat liver endoplasmic reticulum.
- What's new in diuretic therapy.
- When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology